MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Gait, Freezing of Gait and Falls detection using wearable sensors; a systematic review

    A.L. Silvade Lima, L.JW. Evers, T. Hahn, L. Bataille, J.L. Hamilton, M.A. Little, B.R. Bloem, M.J. Faber (Nijmegen, Netherlands)

    Objective: An overview of the use of wearable systems to assess gait, freezing of gait (FOG) and falls in patients with Parkinson’s disease (PD).  Background:…
  • 2017 International Congress

    Wearable sensor-based therapy titration for Parkinson’s Disease

    R. Schmidt, D. Heldman, A. Hadley, D. Riley (Cleveland, OH, USA)

    Objective: To describe a home-based method for improved Parkinson’s therapy titration. Background: Many patients with Parkinson’s disease, due to the location of their residence or…
  • 2017 International Congress

    Personal KinetiGraph Devices Assessing Efficacy of Continuous Enteral Carbidopa/Levodopa Infusion Therapy

    J. Margolesky, C. Luca (Miami, FL, USA)

    Objective: To assess the utility of Personal KinetiGraph (PKG) devices to objectively quantify difference in motor symptoms and motor fluctuations before and after the initiation…
  • 2017 International Congress

    Parkinson’s Disease Medications Availability in Each Philippine Region

    S. Villaraza, C. Go (Manila, Philippines)

    Objective: This study aimed to enumerate the different Parkinson’s disease medications in the Philippines and describe the distribution and availability among the 17 regions of…
  • 2017 International Congress

    Managing severe dyskinesia in Parkinson’s Disease using 24-hour Levodopa/Carbidopa Intestinal Gel Infusion

    B. Cruse, D. Tsui, J. Griffith, H. Morales-Briceno, F. Chang, A. Ha, S. Kim, N. Wolfe, V. Kwan, N. Mahant, V. Fung (Westmead, Australia)

    Objective: We report the effective treatment of troublesome dyskinesias in Parkinson’s disease (PD), unresponsive to 16-hour daytime infusions, using 24-hour Levodopa/Carbidopa Intestinal Gel (LCIG). Background:…
  • 2017 International Congress

    A model community neurofitness and wellness center for people with Parkinson disease. 1-year group pilot data

    E. Borchers, B. Farley, D. Snider, T. McIsaac, J. Bazan-Wigle (Tucson, AZ, USA)

    Objective: Report preliminary one-year benefits of ongoing research-based community group exercise programs integrated with 6-month therapy coaching for people of varying disease severity (to date,…
  • 2017 International Congress

    Inferring the presence of Parkinsonian rest tremor from subthalamic local field potential recordings

    J. Hirschmann, J.-M. Schoffelen, A. Schnitzler, M. van Gerven (Düsseldorf, Germany)

    Objective: To investigate the possibility of tremor detection based on deep brain recordings. Background: Electrophysiological studies have revealed associations between neuronal oscillations in the subthalamic…
  • 2017 International Congress

    Low-frequency repetitive transcranial cerebellar magnetic stimulation as an ‘add-on’ therapy in patients with Essential Tremor

    H.-W. Shin, M. Hallett, Y. Sohn (Bethesda, MD, USA)

    Objective: To investigate effect of cerebellar low-frequency repetitive transcranial magnetic stimulation (rTMS) as an ‘add-on’ treatment on patients with Essential tremor (ET) Background: ET is…
  • 2017 International Congress

    A comparative study between OCT in SCA3 and 10

    F. Tensini, M. Sato, N. Shiokawa, H. Teive (Curitiba, Brazil)

    Objective: To describe OCT findings in spinocerebellar ataxia (SCA) type 10, correlate it with expansion size and disease severity and compare with those of SCA3…
  • 2017 International Congress

    Corticospinal tract dysfunction precede the cerebellar syndrome in spinocerebellar ataxia 2

    R. Rodríguez-Labrada, L. Velázquez-Pérez, R. Torres-Vega, J. Medrano-Montero, Y. Vázquez-Mojena, G. Auburger, U. Ziemann (Holguín, Cuba)

    Objective: To evaluate if corticospinal tract (CST) dysfunction appears before the cerebellar syndrome in SCA2 Background: Studies of corticospinal tract (CST) function in prodromal spinocerebellar…
  • « Previous Page
  • 1
  • …
  • 90
  • 91
  • 92
  • 93
  • 94
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • #23624 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley